Related Experiment Video
Updated: Jul 15, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Innate immune dysregulation in multisystem inflammatory syndrome in children (MIS-C).
Johana Isaza-Correa1,2,3, Laura Ryan1,3, Lynne Kelly1,2,3
1Discipline of Paediatrics, Trinity College, The University of Dublin, Dublin, Ireland.
Pediatric inflammatory multisystem syndrome (MIS-C) involves immune system dysregulation. Children with MIS-C showed altered neutrophil, lymphocyte counts, and cytokine profiles, suggesting potential immunomodulatory treatments.
Area of Science:
- Immunology
- Pediatric Infectious Diseases
- Systemic Inflammation
Background:
- Pediatric inflammatory multisystem syndrome (MIS-C) is a serious condition following SARS-CoV-2 infection.
- The immunopathological mechanisms underlying MIS-C remain incompletely understood.
Purpose of the Study:
- To compare systemic immune responses in children with MIS-C versus healthy controls.
- To investigate cellular and molecular immune alterations in MIS-C patients.
Main Methods:
- Flow cytometry analysis of immune cell populations and receptor expression (CD11b, TLR4) in neutrophils and monocytes.
- Quantification of serum cytokines and inflammasome-related mRNA.
- Assessment of lymphocyte subpopulations (T cells, B cells, NK cells).
Main Results:
- Children with MIS-C exhibited elevated neutrophil counts and reduced lymphocyte counts.
- Increased serum levels of IL-6, IL-10, TNF-β, and VEGF were observed in MIS-C patients.
- Distinct alterations in lymphocyte subsets, including decreased CD3+, NK, and Vδ1 cells, and increased B cells, were noted.
Conclusions:
- MIS-C is characterized by a dysregulated systemic immune response.
- Findings suggest potential therapeutic targets for immunomodulatory interventions in MIS-C.
More Related Videos
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

